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Figure 1.Neutrophils (N) attracted to subcutaneous 80M chitosan implant (chi) degraded the polymer (A--C) and elicited alternatively activated arginase-1+ macrophages (D, arrows). Figure 2.Chitosan-GP/blood implants doubled and sustained arginase-1+ macrophages in subchondral granulation tissues (A), leading to greater trabecular bone regeneration in the microdrill holes (B).
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